Frequency of dyspnea related to intake of ticagrelor or clopidogrel in patients with chronic coronary syndrome undergoing coronary intervention

In patients with chronic coronary syndrome, ticagrelor decreases cardiovascular events more efficiently than clopidogrel. In several studies investigating novel P2Y12 inhibitors dyspnea has been detected. A rise of adenosine blood levels is supposed to be one of cases of dyspnea induced by ticagrelo...

Full description

Bibliographic Details

Published in:	Кардиоваскулярная терапия и профилактика
Main Authors:	Dunya Habeeb Shnain, Ghassan Mohammed Mahmood, Sara Omar Ahmed
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2024-06-01
Subjects:	dyspnea ticagrelor clopidogrel chronic coronary syndrome coronary intervention
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/3970